ArticleJournal of translational medicine2016

Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.

Ahmad Iskandarani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.